Gmail Calendar Documents Reader Web more »
Help | Sign in
Go to Google Groups Home
  
Discussions for Nanogen, Inc. View all discussions

Message from discussion Nanochip product apporoved for GSA == income goes up?
The group you are posting to is a Usenet group. Messages posted to this group will make your email address visible to anyone on the Internet.
Your reply message has not been sent.
Your post was successful
 
From:
To:
Cc:
Followup To:
Add Cc | Add Followup-to | Edit Subject
Subject:
Validation:
For verification purposes please type the characters you see in the picture below or the numbers you hear by clicking the accessibility icon. Listen and type the numbers you hear
 
buckyba...@gmail.com  
View profile  
 More options Apr 4 2007, 10:44 am
From: buckyba...@gmail.com
Date: Wed, 04 Apr 2007 14:44:16 -0000
Local: Wed, Apr 4 2007 10:44 am
Subject: Nanochip product apporoved for GSA == income goes up?
Summary: their nanochip product was approved for sale to a huge
variety of government labs, for use in genetic assays.  The stock
jumped over 30% as a result.  How high do you guys think it'll go?

@@@ Story below: @@@
Nanogen, Inc. (NASDAQ:NGEN), developer of advanced diagnostic
products, announced today that it has obtained a United States
Government Service Administration (GSA) Schedule contract. The
contract, number GS-07F-0283T, applies to the company's NanoChip 400
microarray instrument and reagents.

The contract enables Nanogen to be listed on an approved GSA Schedule
and sell its NanoChip products directly to government agencies such as
the National Institutes of Health (NIH), military hospitals and
Veteran's Administration (VA) hospitals. Nanogen's inclusion as a GSA
Schedule Vendor allows government customers to obtain approved pricing
and license terms from a pre-qualified vendor. Government agencies
typically have separate GSA and non-GSA budgets, and therefore
inclusion as a GSA vendor allows Nanogen broader access to government
customers' budgets.

"Securing a GSA Schedule contract for the NanoChip platform is a
terrific opportunity for Nanogen, because both current and new
customers will be able to expedite future purchases through the GSA
ordering process," said David Ludvigson, Nanogen's president and chief
operating officer. "Increased efficiency, coupled with the opportunity
for immediate implementation, will be the result for customers in the
government sector."

The NanoChip 400 instrument is an automated multiplexing platform that
laboratories use to detect genetic sequences. Tests can be performed
using reagents supplied by Nanogen, or laboratories can develop a
variety of "homebrew" assays. The NanoChip instrument employs
Nanogen's core microarray technology, which utilizes patented
microfluidics and electronic technology to automate sample handling
and detection of results.

Founded in 1949, GSA serves as a centralized procurement and property
management agency for the federal government. GSA manages more than
one-fourth of the government's total procurement dollars and
influences the management of $500 billion in federal assets.

Following this announcement, Nanogen, Inc. (NASDAQ:NGEN), was trading
up over 32% in early trading. The Market Gainer Research Team will
continue to gauge the short and long term affects that this
announcement will have on the company.


    Reply to author    Forward  
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.

Google Home - Terms of Service - Privacy Policy

©2009 Google